Background and Aims: The inflammatory response in preterm parturition is regulated by the innate immune system. Toll-like receptors (TLR)-2 and TLR-4 are innate immune receptors that recognize the microorganisms most frequently involved in amniotic cavity infections, which are associated with activating the inflammatory response at the maternal-fetal interface during preterm labor. This study aimed to evaluate the expression of TLR-2 and TLR-4 in maternal neutrophils in preterm labor. Methods: A cross-sectional study was conducted in the Obstetrics Care Unit of Botucatu Medical School, UNESP, Brazil. The preterm group was composed of 20 pregnant women who presented preterm labor and preterm delivery. The control group was composed of 20 nonlaboring pregnant women matched to the preterm group by gestational age. Neutrophils were isolated from peripheral blood and TLR expressions were performed by real-time polymerase chain reaction and flow cytometry. Results: Gene expressions of TLR-2 and TLR-4 in neutrophils from the preterm group were statistically higher than expressions in neutrophils from the matched control group. The percentage of TLR-4+ neutrophils was higher in the preterm group than the matched control group, while the percentage of TLR-2+ neutrophils did not differ between groups. Conclusion: TLR-4 expression in maternal neutrophils is associated with spontaneous preterm labor.

Keywords:
Pregnancy, Preterm delivery, Innate immunity, Neutrophils, Toll-like receptors
1.
Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA, Nien JK: Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006;11:317-326.
2.
Phillips JB, Abbot P, Rokas A: Is preterm birth a human-specific syndrome? Evol Med public Health 2015;2015:136-148.
3.
Kramer MS, Papageorghiou A, Culhane J, Bhutta Z, Goldenberg RL, Gravett M, et al: Challenges in defining and classifying the preterm birth syndrome. Am J Obstet Gynecol 2012;206:108-112.
4.
Gotsch F, Romero R, Erez O, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, et al: The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 2009;22(suppl 2):5-23.
5.
Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
6.
Moutquin JM: Classification and heterogeneity of preterm birth. BJOG 2003;110(suppl 20):30-33.
7.
Pretorius C, Jagatt A, Lamont RF: The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 2007;35:93-99.
8.
Mysorekar IU, Cao B: Microbiome in parturition and preterm birth. Semin Reprod Med 2014;32:50-55.
9.
Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Mathews TJ: Births: final data for 2011. Natl Vital Stat Rep 2013;62:1-69, 72.
10.
Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al: The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-38.
11.
Patni S, Flynn P, Wynen LP, Seager AL, Morgan G, White JO, et al: An introduction to toll-like receptors and their possible role in the initiation of labour. BJOG 2007;114:1326-1334.
12.
Albiger B, Dahlberg S, Henriques-Normark B, Normark S: Role of the innate immune system in host defence against bacterial infections: focus on the toll-like receptors. J Intern Med 2007;261:511-528.
13.
Carpenter S, O'Neill LA: How important are toll-like receptors for antimicrobial responses? Cell Microbiol 2007;9:1891-1901.
14.
Brodsky I, Medzhitov R: Two modes of ligand recognition by TLRs. Cell 2007;130:979-981.
15.
DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al: Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 2008;3:e3056.
16.
Nguyen DP, Gerber S, Hohlfeld P, Sandrine G, Witkin SS: Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004;32:323-326.
17.
Perni SC, Vardhana S, Korneeva I, Tuttle SL, Paraskevas LR, Chasen ST, et al: Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004;191:1382-1386.
18.
Yoon B, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, et al: The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003;189:919-924.
19.
Rinaldi SF, Hutchinson JL, Rossi AG, Norman JE: Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Rev Clin Immunol 2011;7:675-696.
20.
Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F: Inflammation and pregnancy. Reprod Sci 2009;16:206-215.
21.
Amirchaghmaghi E, Taghavi SA, Shapouri F, Saeidi S, Rezaei A, Aflatoonian R: The role of toll like receptors in pregnancy. Int J Fertil Steril 2013;7:147-154.
22.
Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34.
23.
Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 2010;11:373-384.
24.
Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
25.
Kawasaki T, Kawai T: Toll-like receptor signaling pathways. Front Immunol 2014;5:461.
26.
Piccinini AM, Midwood KS: DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010;2010:pii:672395.
27.
Qian C, Cao X: Regulation of toll-like receptor signaling pathways in innate immune responses. Ann N Y Acad Sci 2013;1283:67-74.
28.
Kawai T, Akira S: The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21:317-337.
29.
Reuven EM, Fink A, Shai Y: Regulation of innate immune responses by transmembrane interactions: lessons from the TLR family. Biochim Biophys Acta 2014;1838:1586-1593.
30.
Kawai T, Akira S: TLR signaling. Cell Death Differ 2006;13:816-825.
31.
Kang JY, Lee JO: Structural biology of the toll-like receptor family. Annu Rev Biochem 2011;80:917-941.
32.
Akira S: Mammalian toll-like receptors. Curr Opin Immunol 2003;15:5-11.
33.
Lee Y, Allport V, Sykes A, Lindstrom T, Slater D, Bennett P: The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol Hum Reprod 2003;9:213-218.
34.
Thaxton JE, Nevers TA, Sharma S: TLR-mediated preterm birth in response to pathogenic agents. Infect Dis Obstet Gynecol 2010;2010:pii:378472.
35.
Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S: The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
36.
Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, et al: Prostaglandins and mechanisms of preterm birth. Reproduction 2002;124:1-17.
37.
Phillippe M, Elovitz M, Saunders T: Thrombin-stimulated uterine contractions in the pregnant and nonpregnant rat. J Soc Gynecol Investig 2001;8:260-265.
38.
Moço NP, Martin LF, Pereira AC, Polettini J, Peraçoli JC, Coelho KI, et al: Gene expression and protein localization of TLR-1, -2, -4 and -6 in amniochorion membranes of pregnancies complicated by histologic chorioamnionitis. Eur J Obstet Gynecol Reprod Biol 2013;171:12-17.
39.
Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y: Immunohistochemical distribution of toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum Pathol 2004;35:47-54.
40.
Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, et al: Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004;191:1346-1355.
41.
Rindsjö E, Holmlund U, Sverremark-Ekström E, Papadogiannakis N, Scheynius A: Toll-like receptor-2 expression in normal and pathologic human placenta. Hum Pathol 2007;38:468-473.
42.
Prince LR, Whyte MK, Sabroe I, Parker LC: The role of TLRs in neutrophil activation. Curr Opin Pharmacol 2011;11:397-403.
43.
Zarember KA, Godowski PJ: Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168:554-561.
44.
Salomao R, Brunialti MK, Gomes NE, Mendes ME, Diaz RS, Komninakis S, et al: Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 2009;37:132-139.
45.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
46.
Agrawal V, Hirsch E: Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 2012;17:12-19.
47.
Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM: Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008;79:50-57.
48.
Ilievski V, Lu SJ, Hirsch E: Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci 2007;14:315-320.
49.
Montalbano AP, Hawgood S, Mendelson CR: Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes. Endocrinology 2013;154:483-498.
50.
Wahid HH, Dorian CL, Chin PY, Hutchinson MR, Rice KC, Olson DM, et al: Toll-like receptor 4 is an essential upstream regulator of on-time parturition and perinatal viability in mice. Endocrinology 2015;156:3828-3841.
51.
Elovitz MA, Mrinalini C: Animal models of preterm birth. Trends Endocrinol Metab 2004;15:479-487.
52.
Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M: A new model for inflammation-induced preterm birth: the role of platelet-activating factor and toll-like receptor-4. Am J Pathol 2003;163:2103-2111.
53.
Wang H, Hirsch E: Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 2003;69:1957-1963.
54.
Pawelczyk E, Nowicki BJ, Izban MG, Pratap S, Sashti NA, Sanderson M, et al: Spontaneous preterm labor is associated with an increase in the proinflammatory signal transducer TLR4 receptor on maternal blood monocytes. BMC Pregnancy Childbirth 2010;10:66.
55.
Marconi C, de Andrade Ramos BR, Peraçoli JC, Donders GG, da Silva MG: Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol 2011;65:549-556.
56.
Noda-Nicolau NM, Polettini J, Peltier MR, da Silva MG, Menon R: Combinations and loads of bacteria affect the cytokine production by fetal membranes: an in vitro study. Am J Reprod Immunol 2016;76:504-511.
57.
Vogel C, Marcotte EM: Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2013;13:227-232.
58.
Mendz GL, Kaakoush NO, Quinlivan JA: Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women. Front Cell Infect Microbiol 2013;3:58.
59.
Challis JRG: Mechanism of parturition and preterm labor. Obstet Gynecol Surv 2000;55:650-660.
60.
Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I: Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995;22:281-342.
61.
Menon R, Boldogh I, Hawkins HK, Woodson M, Polettini J, Syed TA, Fortunato SJ, et al: Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol 2014;184:1740-1751.
62.
Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T: Cytokine production in chorioamnionitis. J Reprod Immunol 2000;47:185-196.
63.
Osmers R, Rath W, Adelmann-Grill BC, Fittkow C, Kuloczik M, Szeverenyi M, et al: Origin of cervical collagenase during parturition. Am J Obstet Gynecol 1992;166:1455-1460.
64.
Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, et al: Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998-6004.
65.
O'Mahony DS, Pham U, Iyer R, Hawn TR, Liles WC: Differential constitutive and cytokine-modulated expression of human toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci 2008;5:1-8.
66.
Galazios G, Papazoglou D, Giagloglou K, Vassaras G, Maltezos E, Anastasiadis P: Interleukin-6 levels in umbilical artery serum in normal and abnormal pregnancies. Int J Gynaecol Obstet 2002;78:147-151.
67.
Torbé A: Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm 2007;2007:35782.
68.
Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, et al: Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;27:631-640.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.